![](/img/cover-not-exists.png)
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China
Guan, Haijing, Sheng, Yanan, Guo, Wanjie, Han, Sheng, Shi, LuwenLanguage:
english
Journal:
Advances in Therapy
DOI:
10.1007/s12325-019-00908-7
Date:
March, 2019
File:
PDF, 742 KB
english, 2019